BAP1 and cancer: BAP1-defective cancers: High metastatic risk and lower survival ratesCAR T-cell therapy: Early-stage clinical trials, results pending; HLA downregulation or loss on cancer cells can limit the therapy effectivenessHuman endogenous retroviruses (HERVs): Need more research to confirm clinical relevance